Headline
The latest stories from AHA Today.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Oct. 1 announced that it will meet later this month for a pair of significant discussions on COVID-19 vaccines.
The Federal Emergency Management Agency last week released guidance intended to streamline the application process for hospital generator projects under its Hazard Mitigation Assistance programs.
The Health Resources and Services Administration Oct. 5 will host the second in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds.
El Camino Health in Mountain View, Calif., will host a free virtual symposium Oct. 7 on maternal mental health.
The AHA is accepting applications through Oct. 15 for its 2022 Quest for Quality Prize.
The Food and Drug Administration approved for marketing a computed tomography imaging device that uses advanced technology to help clinicians better diagnose and treat disease.
At least 93% of clinicians eligible to participate in Medicare’s Merit-based Incentive Payment System earned a small positive adjustment in 2017 through 2019, according to a report released by the Government Accountability Office.
The Centers for Disease Control and Prevention has awarded $3 million for 20 planning grants to accelerate public health strategies that reduce the burden of chronic disease among people experiencing health disparities and inequities.
The Substance Abuse and Mental Health Services Administration distributed $825 million in grants from the 2021 Consolidated Appropriations Act and Coronavirus Response and Relief Supplement to 231 community mental health centers to expand access to services.
The Centers for Medicare & Medicaid Services released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2022 calendar year.